Is Medicare drug coverage in jeopardy?
Republican committee leaders are pushing the Obama administration to call off proposed changes to the Medicare prescription drug program, arguing the overhaul would jeopardize seniors' plans and raise premiums. The charges pertain to recent regulations proposed by the Centers for Medicare and Medicaid Services (CMS). The rules would allow the agency to participate in negotiations between insurance companies and pharmacies in Medicare Part D for the first time out of concerns over cost and access. Supporters of the change argue the CMS needs new authority to ensure the market for prescription drugs in Part D works for patients.
- Anthem Blue Cross, 7 CA Health Systems Create New Challenger, Business Model
- Data Points to Boom in Private HIX
- Few Winners Among MSSP Participants
- EHR Systems 'Immature, Costly,' AMA Says
- Technology Lights Up Health Innovation Forum
- Interstate Medical Licensure Effort Advances
- Hospitals and doctors fail patients by passing the buck on insurance rules
- Malnourishment 'Epidemic' Plagues Hospitals? Really?
- A new way insurers are shifting costs to the sick
- FTC wary of mergers by hospitals